Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Sex reversal following deletion of a single distal enhancer of Sox9.

Gonen N, Futtner CR, Wood S, Garcia-Moreno SA, Salamone IM, Samson SC, Sekido R, Poulat F, Maatouk DM, Lovell-Badge R.

Science. 2018 Jun 29;360(6396):1469-1473. doi: 10.1126/science.aas9408. Epub 2018 Jun 14.

PMID:
29903884
2.

The VEGF and PEDF levels in the follicular fluid of patients co- treated with LETROZOLE and gonadotropins during the stimulation cycle.

Haas J, Bassil R, Gonen N, Meriano J, Jurisicova A, Casper RF.

Reprod Biol Endocrinol. 2018 May 29;16(1):54. doi: 10.1186/s12958-018-0367-5.

3.

An integrated computational and experimental study uncovers FUT9 as a metabolic driver of colorectal cancer.

Auslander N, Cunningham CE, Toosi BM, McEwen EJ, Yizhak K, Vizeacoumar FS, Parameswaran S, Gonen N, Freywald T, Bhanumathy KK, Freywald A, Vizeacoumar FJ, Ruppin E.

Mol Syst Biol. 2017 Dec 1;13(12):956. doi: 10.15252/msb.20177739.

4.

Does daily co-administration of letrozole and gonadotropins during ovarian stimulation improve IVF outcome?

Haas J, Bassil R, Meriano J, Samara N, Barzilay E, Gonen N, Casper RF.

Reprod Biol Endocrinol. 2017 Aug 30;15(1):70. doi: 10.1186/s12958-017-0288-8.

5.

New Role for Interleukin-13 Receptor α1 in Myocardial Homeostasis and Heart Failure.

Amit U, Kain D, Wagner A, Sahu A, Nevo-Caspi Y, Gonen N, Molotski N, Konfino T, Landa N, Naftali-Shani N, Blum G, Merquiol E, Karo-Atar D, Kanfi Y, Paret G, Munitz A, Cohen HY, Ruppin E, Hannenhalli S, Leor J.

J Am Heart Assoc. 2017 May 20;6(5). pii: e005108. doi: 10.1161/JAHA.116.005108.

6.

Correction: Normal Levels of Sox9 Expression in the Developing Mouse Testis Depend on the TES/TESCO Enhancer, but This Does Not Act Alone.

Gonen N, Quinn A, O'Neill HC, Koopman P, Lovell-Badge R.

PLoS Genet. 2017 Feb 1;13(2):e1006584. doi: 10.1371/journal.pgen.1006584. eCollection 2017 Feb.

7.

Normal Levels of Sox9 Expression in the Developing Mouse Testis Depend on the TES/TESCO Enhancer, but This Does Not Act Alone.

Gonen N, Quinn A, O'Neill HC, Koopman P, Lovell-Badge R.

PLoS Genet. 2017 Jan 3;13(1):e1006520. doi: 10.1371/journal.pgen.1006520. eCollection 2017 Jan. Erratum in: PLoS Genet. 2017 Feb 1;13(2):e1006584.

8.

Salt intake is associated with inflammation in chronic heart failure.

Azak A, Huddam B, Gonen N, Yilmaz SR, Kocak G, Duranay M.

Int Cardiovasc Res J. 2014 Sep;8(3):89-93. Epub 2014 Sep 1.

9.

Severe hypoxia induces complete antifolate resistance in carcinoma cells due to cell cycle arrest.

Raz S, Sheban D, Gonen N, Stark M, Berman B, Assaraf YG.

Cell Death Dis. 2014 Feb 20;5:e1067. doi: 10.1038/cddis.2014.39.

10.

Homothorax plays autonomous and nonautonomous roles in proximodistal axis formation and migration of the Drosophila renal tubules.

Zohar-Stoopel A, Gonen N, Mahroum M, Ben-Zvi DS, Toledano H, Salzberg A.

Dev Dyn. 2014 Jan;243(1):132-44. doi: 10.1002/dvdy.24011. Epub 2013 Jul 29.

11.

Antifolates in cancer therapy: structure, activity and mechanisms of drug resistance.

Gonen N, Assaraf YG.

Drug Resist Updat. 2012 Aug;15(4):183-210. doi: 10.1016/j.drup.2012.07.002. Epub 2012 Aug 23. Review.

PMID:
22921318
12.

Anti-cyclic citrullinated peptides positivity rate in patients with familial Mediterranean fever.

Ceri M, Unverdi S, Altay M, Ureten K, Oztürk MA, Gönen N, Duranay M.

Clin Exp Rheumatol. 2010 Jul-Aug;28(4 Suppl 60):S58-61. Epub 2010 Sep 24.

PMID:
20868572
13.

The obligatory intestinal folate transporter PCFT (SLC46A1) is regulated by nuclear respiratory factor 1.

Gonen N, Assaraf YG.

J Biol Chem. 2010 Oct 29;285(44):33602-13. doi: 10.1074/jbc.M110.135640. Epub 2010 Aug 19.

14.

Functional elements in the minimal promoter of the human proton-coupled folate transporter.

Stark M, Gonen N, Assaraf YG.

Biochem Biophys Res Commun. 2009 Oct 9;388(1):79-85. doi: 10.1016/j.bbrc.2009.07.116. Epub 2009 Jul 28.

PMID:
19643086
15.

PCFT/SLC46A1 promoter methylation and restoration of gene expression in human leukemia cells.

Gonen N, Bram EE, Assaraf YG.

Biochem Biophys Res Commun. 2008 Nov 28;376(4):787-92. doi: 10.1016/j.bbrc.2008.09.074. Epub 2008 Sep 24.

PMID:
18817749
16.

Membranoproliferative glomerulonephritis associated with pseudoxanthoma elasticum.

Altay M, Turgut F, Karakurt F, Kaya R, Ecemis Z, Gonen N, Akcay A, Duranay M.

Int Urol Nephrol. 2008;40(4):1099-101. doi: 10.1007/s11255-007-9290-y. Epub 2008 Jan 19.

PMID:
18205024
17.
18.

Comparison between risperidone, olanzapine, and clozapine in the management of chronic schizophrenia: a naturalistic prospective 12-week observational study.

Strous RD, Kupchik M, Roitman S, Schwartz S, Gonen N, Mester R, Weizman A, Spivak B.

Hum Psychopharmacol. 2006 Jun;21(4):235-43.

PMID:
16783815
19.

Recovery of cyanide in gold leach waste solution by volatilization and absorption.

Gönen N, Kabasakal OS, Ozdil G.

J Hazard Mater. 2004 Sep 10;113(1-3):231-6.

PMID:
15363536
20.

Clozapine in the treatment of obsessive-compulsive symptoms in schizophrenia patients: a case series study.

Reznik I, Yavin I, Stryjer R, Spivak B, Gonen N, Strous R, Mester R, Weizman A, Kotler M.

Pharmacopsychiatry. 2004 Mar;37(2):52-6.

PMID:
15048611
21.

Combined electroconvulsive-clozapine therapy.

Kupchik M, Spivak B, Mester R, Reznik I, Gonen N, Weizman A, Kotler M.

Clin Neuropharmacol. 2000 Jan-Feb;23(1):14-6.

PMID:
10682225
22.

The effect of long-term antipsychotic treatment on the body weight of patients suffering from chronic schizophrenia: clozapine versus classical antipsychotic agents.

Spivak B, Musin E, Mester R, Gonen N, Talmon Y, Guy N, Roitman S, Kupchik M, Kotler M, Weizman A.

Int Clin Psychopharmacol. 1999 Jul;14(4):229-32.

PMID:
10468315
23.

Diminished suicidal and aggressive behavior, high plasma norepinephrine levels, and serum triglyceride levels in chronic neuroleptic-resistant schizophrenic patients maintained on clozapine.

Spivak B, Roitman S, Vered Y, Mester R, Graff E, Talmon Y, Guy N, Gonen N, Weizman A.

Clin Neuropharmacol. 1998 Jul-Aug;21(4):245-50.

PMID:
9704166
24.

Trihexyphenidyl treatment of clozapine-induced hypersalivation.

Spivak B, Adlersberg S, Rosen L, Gonen N, Mester R, Weizman A.

Int Clin Psychopharmacol. 1997 Jul;12(4):213-5.

PMID:
9347382
25.

Clozapine treatment for neuroleptic-induced tardive dyskinesia, parkinsonism, and chronic akathisia in schizophrenic patients.

Spivak B, Mester R, Abesgaus J, Wittenberg N, Adlersberg S, Gonen N, Weizman A.

J Clin Psychiatry. 1997 Jul;58(7):318-22.

PMID:
9269253
26.

Neuroleptic malignant syndrome associated with abrupt withdrawal of anticholinergic agents.

Spivak B, Gonen N, Mester R, Averbuch E, Adlersberg S, Weizman A.

Int Clin Psychopharmacol. 1996 Sep;11(3):207-9.

PMID:
8923101
27.

Problems in implementing the 1991 Treatment of Mental Patients Law in Israel.

Mester R, Mendel A, Gonen N, Becker D, Adlesberg S.

Isr J Psychiatry Relat Sci. 1995;32(2):102-7; discussion 108.

PMID:
7558754
28.

The delusion based will: the question of validity.

Mester R, Toren P, Gonen N.

Med Law. 1994;13(5-6):555-61.

PMID:
7845185
29.

The psychiatric patient as consumer.

Mester R, Gonen N.

Med Law. 1993;12(3-5):389-92.

PMID:
8231711
30.

Are confinement and treatment synonyms?

Becker D, Gonen N, Floru S.

Med Law. 1990;9(3):904-9.

PMID:
2122159
31.

Injuries in attempted suicide by jumping from a height.

Katz K, Gonen N, Goldberg I, Mizrahi J, Radwan M, Yosipovitch Z.

Injury. 1988 Nov;19(6):371-4.

PMID:
3267637
32.

Platelet [3H]imipramine binding in autism and schizophrenia.

Weizman A, Gonen N, Tyano S, Szekely GA, Rehavi M.

Psychopharmacology (Berl). 1987;91(1):101-3.

PMID:
3103151
33.

Effect of chlorpromazine on hypothalamic-pituitary-gonadal function in 10 adolescent schizophrenic boys.

Apter A, Dickerman Z, Gonen N, Assa S, Prager-Lewin R, Kaufman H, Tyano S, Laron Z.

Am J Psychiatry. 1983 Dec;140(12):1588-91.

PMID:
6359897

Supplemental Content

Support Center